Please sign in to follow a disease.
Sirnaomics
Clinical trials sponsored by Sirnaomics, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a single injection silence a clotting protein and prevent strokes? Results expected May 2027 (estimated)
- Injection targets double chin fat without surgery Results expected Jul 2027 (estimated)
-
Can a single injection silence a clotting protein and prevent strokes?
Disease control OngoingThis trial tests an experimental drug called FXI-GalNAc-siRNA, which uses RNA technology to temporarily lower a clotting protein in the blood. The goal is to see if a single injection is safe and how the body processes it in healthy adults aged 18 to 55. If it works, this approac…
Phase 1 • Sponsor: Sirnaomics • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can a Gene-Targeting injection make hypertrophic scars fade?
Symptom relief CancelledThis trial investigates whether STP705, an injection that uses small interfering RNA to block scar-promoting proteins, can safely improve hypertrophic scars. Adults aged 18 to 45 with linear hypertrophic scars will receive weekly injections into the scar for four weeks. The study…
Phase 1/2 • Sponsor: Sirnaomics • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC